Co-PSMA Trial: Head-to-Head Comparison of 64Cu-SAR-bis-PSMA vs 68Ga-PSMA-11

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr. Louise Emmett breaks down the rationale behind the Co-PSMA trial, a head-to-head comparison study evaluating the ⁶⁴Cu-SAR-bisPSMA and ⁶⁸Ga-PSMA-11 imaging agents. Dr. Emmett explains how copper-based PSMA imaging could improve sensitivity, provide an extended imaging window, and impact treatment decisions for patients with biochemical recurrence post-radical prostatectomy. She also explores the real-world implications of delayed imaging, logistical considerations, and what’s next for clinical adoption if the trial demonstrates superior performance.
Category
Urology
Be the first to comment

Up Next